Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel.
| Website | http://vaxxel.fr/ |
| Employees | 10 (1 on RocketReach) |
| Founded | 2019 |
| Address | 43, Boulevard du 11 Novembre 1918, Villeurbanne, Auvergne-Rhône-Alpes 69100, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Vaccine Development, Viral Vaccines, Vaccine Research, Vaccine Technology, Novel Vaccines, Immunology Research, Infectious Disease Research, Biotechnology, Pharmaceutical Research, Drug Discovery, Viral Vector Vaccines, Preclinical Research |
| Competitors | Sanofi Pasteur, Merck & Co., Inc., GSK, Pfizer, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Moderna Therapeutics, Gilead Sciences, Novartis, Bristol Myers Squibb +43 more (view full list) |
Looking for a particular Vaxxel employee's phone or email?
1 people are employed at Vaxxel.
Vaxxel is based in Villeurbanne, Auvergne-Rhône-Alpes.